Association of PTPRT Mutations with Cancer Metastasis in Multiple Cancer Types

Table 2

The neoantigens derived from recurrent PTPRT mutations in pan-cancer.

Chr	Location	AA-change	Peptide	Frequency	HLA types
chr20	40790168	G826R	RELSQPTLTI	5	HLA-B44:02
chr20	40735467	R1117C	GVVDIFNCVC	4	HLA-A02:06
chr20	41385177	V262I	ADTAQRSISK	4	HLA-A11:01
chr20	40727077	E1280V	VMLNVMDTA	3	HLA-A02:05; HLA-B35:01; HLA-B42:01; HLA-C07:01; HLA-C08:02
chr20	41419951	V124M	RSSPGALNVYM	3	HLA-A30:02
chr20	41420025	D99G	LLLPTLKENGT	2	HLA-A02:01
chr20	40747103	M977I	TVKDFWRIIW	2	HLA-B57:01
chr20	41101110	R416C	EPFGYAVTCCH	2	HLA-B07:02; HLA-A02:01
chr20	40864873	Y780H	YSYSYHLKLA	2	HLA-A30:01; HLA-C06:02; HLA-C03:03
chr20	40911144	R721C	GETKINCVC	2	HLA-B40:01
chr20	41306583	R359Q	YEIQVLLTR	2	HLA-B40:01
chr20	40980816	Y557C	HLFVGLCPGT	2	HLA-A02:01
chr20	40877418	V741M	KQMDNTVKMA	2	HLA-A02:06; HLA-B40:03; HLA-C03:04
chr20	40713337	T1393I	REGRIVVHCL	2	HLA-B40:01
chr20	40713431	Y1343N	WPANRDTPP	2	HLA-B55:01
chr20	40730915	R1188H	TLNIVTPHV	2	HLA-A02:01